Aditxt, Inc. Common Stock (ADTX)

Price$0.06

Growth ScoreF

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-111.38%

Price vs S&P 500 (4W)-101.04%

VGM Score1.97

Market Capitalization$50,669

All Metrics

Book Value / Share (Quarterly)$368.09

P/TBV (Annual)0.08x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-84.90%

Cash Flow / Share (Quarterly)$-1686.49

Price vs S&P 500 (YTD)-110.98%

Gross Margin (TTM)8.44%

Net Profit Margin (TTM)-1303569.06%

EPS (TTM)$-211586.20

10-Day Avg Trading Volume23.03M

EPS Excl Extra (TTM)$-211586.20

EPS (Annual)$-30227.68

ROI (Annual)-558.79%

Gross Margin (Annual)8.44%

Net Profit Margin (5Y Avg)-275884.71%

Cash / Share (Quarterly)$209.88

Revenue Growth QoQ (YoY)-86.48%

ROA (Last FY)-252.56%

Revenue Growth TTM (YoY)-99.91%

EBITD / Share (TTM)$-31649.60

ROE (5Y Avg)-463.97%

Operating Margin (TTM)-614207.81%

Cash Flow / Share (Annual)$-1686.49

P/B Ratio0.01x

P/B Ratio (Quarterly)0.08x

Net Income / Employee (Annual)$-1,604,400

EV / Revenue (TTM)-403.91x

Net Interest Coverage (TTM)-18.69x

ROA (TTM)-180.91%

EPS Incl Extra (Annual)$-30227.68

Current Ratio (Annual)0.31x

Quick Ratio (Quarterly)0.26x

3-Month Avg Trading Volume2.64M

52-Week Price Return-100.00%

Revenue / Employee (TTM)$100

Tangible BV / Share (Quarterly)$367.91

P/S Ratio (Annual)15.83x

Asset Turnover (Annual)0.00x

52-Week High$53451.36

Operating Margin (5Y Avg)-136466.04%

EPS Excl Extra (Annual)$-30227.68

CapEx CAGR (5Y)-39.53%

Tangible BV CAGR (5Y)-12.11%

26-Week Price Return-99.99%

Quick Ratio (Annual)0.26x

13-Week Price Return-99.92%

Total Debt / Equity (Annual)0.33x

Current Ratio (Quarterly)0.31x

Enterprise Value$-1.29M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$100

Inventory Turnover (Annual)0.34x

Pretax Margin (Annual)-1337095.00%

Cash / Share (Annual)$209.88

3-Month Return Std Dev201.87%

Gross Margin (5Y Avg)-66.32%

Net Income / Employee (TTM)$-1,604,400

ROE (Last FY)-743.61%

Net Interest Coverage (Annual)-18.69x

EPS Basic Excl Extra (Annual)$-30227.68

Receivables Turnover (TTM)0.03x

Total Debt / Equity (Quarterly)0.33x

EPS Incl Extra (TTM)$-211586.20

Receivables Turnover (Annual)0.59x

ROI (TTM)-118.33%

P/S Ratio (TTM)15.83x

Pretax Margin (5Y Avg)-282675.87%

Revenue / Share (Annual)$2.32

Tangible BV / Share (Annual)$367.91

Price vs S&P 500 (52W)-127.04%

Year-to-Date Return-99.96%

5-Day Price Return-34.30%

EPS Normalized (Annual)$-30227.68

ROA (5Y Avg)-193.63%

Net Profit Margin (Annual)-1303568.75%

Month-to-Date Return-34.30%

Cash Flow / Share (TTM)$-201.51

EBITD / Share (Annual)$-14047.38

Operating Margin (Annual)-614207.81%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-361.59%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-211586.20

P/TBV (Quarterly)0.08x

P/B Ratio (Annual)0.08x

Inventory Turnover (TTM)0.34x

Pretax Margin (TTM)-1337095.31%

Book Value / Share (Annual)$368.09

Price vs S&P 500 (13W)-110.43%

Beta0.85x

Revenue / Share (TTM)$2.32

ROE (TTM)-150.77%

52-Week Low$0.07

gGradeF

mGradeF

vgmGradeF

Show chart for

Analyst Recommendations

Apr 2024

May 2024

Jun 2024

Jul 2024

4.00

2.17

4.00

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ADTXAditxt, Inc. Common Stock	—	F	F	$0.06
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Aditxt Inc is a life sciences company developing immunomodulatory therapies focused on organ transplant tolerance and autoimmune disease treatment. Its pipeline includes Adimune, AditxtScore, and ADI-100, a novel Apoptotic DNA Immunotherapy designed to induce immune tolerance to transplanted organs by mimicking the body's natural tolerance mechanisms.